Financials
- Market Capitalization 2.01 B
- Employee 307
- Founded 2018
- CEO David Hung
- Website www.nuvationbio.com
- Headquarter Delaware, United States
- FIGI BBG00VHJ0CC1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-14.93
ratio cours/chiffre d'affaires
0.05
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1977 | ANAB AnaptysBio, Inc. - Common Stock | 69.81 USD | +5.15% | +12.18% | +23.25% | +98.32% | 2.03 B USD | ||
| 1979 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 22.89 USD | -3.05% | +2.28% | +25.63% | +131.21% | 2.03 B USD | ||
| 1989 | ABCL AbCellera Biologics Inc. - Common Shares | 6.52 USD | -4.12% | -21.63% | +19.20% | +47.85% | 1.99 B USD | ||
| 1990 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.82 USD | -0.69% | -2.34% | +20.03% | -3.59% | 1.99 B USD |